Ministry of Education and Science, Republic of Kazakhstan
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction
Role: collaborator
Immunological Profile and Microbial Markers in Evaluating the Effectiveness of Probiotic Therapy in RA Patients
Role: collaborator
Innovative Technologies for the Treatment of Pulmonary and Heart Failure
Role: collaborator
Organ-substituting Technologies in the Treatment of Heart and Pulmonary Failure
Role: collaborator
The Sublimated Mare Milk Supplement's Effect on Gut Mucosal Lining After Antibiotics
Role: collaborator
The Sublimated Mare Milk Supplement in Hepatitis C
Role: collaborator
Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients
Role: collaborator
Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
Role: collaborator
Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis
Role: collaborator
All 9 trials loaded